Characteristics of an Ideal Performance Measure a focus on developing outcomes measures that are linked to meaningful patient outcomes that can be infl uenced by cardiac or pulmonary rehabilitation. The ultimate goal of this project was to provide the tools and standards that programs would need to ensure high-quality clinical care and ultimately improve patient outcomes. As pulmonary rehabilitation (PR) already had 2 validated PMs that were endorsed by the National Quality Forum, 9 , 10 this effort primarily focused on CR PMs but also included developing 1 additional PM for PR programs.
METHODS
In the fall of 2014, the QCC began a deliberate and systematic approach to choosing, writing, and validating new PMs. The QCC followed a distinct 3-step process that included a modifi ed Delphi approach that included structured, purposeful, and repeated cycles of QCC and AACVPR membership involvement to ensure stake holder engagement. 11 First, we surveyed national AACVPR leadership and AACVPR members working as CR medical directors and program directors to identify and rank various potential PM topics. Next, we assessed the face validity of the drafted PMs in a second national survey. Finally, the inter-and intrarater reliability of each PM was assessed by abstracting patient charts at programs throughout the United States. As a quality improvement effort, institutional review board approval was not required for the fi rst 2 steps because individual patient data were not included, and all surveys were anonymous. For the third step, institutional review board permission at both Helen Hayes Hospital in Haverstraw, New York (project planning and implementation), and at Baystate Medical Center in Springfi eld, Massachusetts (data collection and analysis), was obtained. In both cases, the project was determined to be exempt because it did not meet the federal defi nition of human subjects' research.
In an effort to identify key areas for PM development, the QCC utilized the core components of both cardiac and pulmonary rehabilitation 12 , 13 in addition to several other potential topic areas. A survey regarding these topic areas was then sent to all current program directors and medical directors, as well as current and former AACVPR leaders, fellows, board members, and state affi liate board members. We surveyed professionals in both cardiac and pulmonary rehabilitation but they responded only to questions directly related to their area(s) of focus and specialization. The survey asked respondents to rate each of the potential topics on 8 characteristics ( Table 1 ) , utilizing a Likert scale ranked from 1 to 4, using the following response scale: strongly disagree, disagree, agree, and strongly agree. A free-text comment was also included for each topic area. The survey was distributed in December 2014 and used www.surveymonkey.com as the electronic platform. Participation was voluntary, no incentive was provided, and only 1 survey request was sent to each potential respondent. Participants also answered several basic questions about themselves and their roles, experience, and responsibilities. To avoid mixing responses and increase transparency, the members of the QCC also completed the survey and these results were recorded separately.
After selection of the highest priority PM topics, 1 member of the QCC drafted each PM with input from other members of the QCC and an ACCVPR experts group, as needed. Initial drafts were reviewed by the QCC and were modifi ed for clarity and content. To assess face validity of the proposed measures, a second survey was then sent to all current AACVPR board members, AACVPR committee members, and state affi liate presidents to establish face validity of the PMs using similar methods as the fi rst survey, except that Likert scale questions were now ranked from 1 to 5 with an additional middle ranking of 3 (neither agree nor disagree). Participants were asked to rate each PM according to both the 8 ideal characteristics of a PM ( Table 1 ) , as well as clarity of the PM language and defi nitions. Each PM had a free-text section for comments. Results of this survey were discussed by the QCC and needed adaptations in language and defi nitions were made by the PM authors.
In the third step of this project, we assessed the feasibility and reliability of the PMs using structured chart abstraction, as described previously. 14 We fi rst solicited volunteer programs from the AACVPR program directory, each of which participated in the project to the extent feasible. However, because of different populations and resources available, only a few programs were able to abstract every PM. Each participating program then identifi ed 3 staff members to participate in the abstraction process for the PMs they volunteered for. One staff member (site coordinator) identifi ed 35 patient charts through purposeful sampling where about 30 of the charts qualifi ed for the measure denominator and 5 of the charts did not, which were then placed in random order. Next, the site coordinator then provided this list of 35 patients to the 2 other staff members, who reviewed each patient chart to see whether the patient met the PM. First, they reviewed the denominator (does the patient have the condition?), then the exclusion (is there an exclusion present?), and fi nally whether the patient met the numerator (was the PM met?). They recorded the time needed to complete the chart abstraction and any feasibility issues encountered. All answers were entered into REDCap, a secure online research application that allows multiple users to enter data simultaneously from different locations. 15 At no point were names or other identifying information entered into REDCap. Then, 1 to 2 wk later, the 2 abstractors again reviewed the same 35 patients following the same procedures as previously noted, so that each individual chart was reviewed 4 times for each PM.
STATISTICAL ANALYSIS
For the prioritization survey and the face validity survey, we averaged the 8 Likert-scale scores of each domain ( Table 1 ) into a single score for each PM. As an alternate measure of priority, we then ranked each PM within each of the 8 domains from highest score to lowest score. Performance measures were given 1 point for each individual domain score within the top 5. These points were then summed across domains with a summary score range between 0 and 8. In both surveys, comments were summarized, discussed, and needed changes were made to the PMs.
For the reliability assessment phase, all 4 chart abstractions were assembled on the same patient chart for each PM to facilitate calculation of inter and intrarater reliability. Time required for chart abstraction was averaged across each PM for both the fi rst and second chart abstraction. We used Cohen κ statistic to assess agreement at each step of the PM, including agreement at the denominator, exclusions, and numerator levels. We calculated agreement as a combined group. We considered a κ value of ≥ 0.8 to be excellent agreement, 0.61 to 0.79 to be good agreement, 0.41 to 0.60 to be fair agreement, and ≤ 0.4 to be poor/unacceptable agreement. All calculations were performed on JMP version 12.0.1 (SAS Institute) and Microsoft Excel (2010).
RESULTS
The prioritization survey for both CR and PR was sent to 1562 professionals, of which 302 (19.3%) completed the survey. Of these 302 completers, 214 (70.9%) and 88 (29.1%) were CR and PR professionals, respectively. The majority of participants were program directors with master's degrees in either nursing or exercise physiology, who had more than 15 y of experience ( Table 2 ) . For CR, of the 14 potential PMs, blood pressure control, improvement in functional capacity, diabetes self-management, psychosocial risk, and abstinence from tobacco use had the highest number of domains ranked in the top 5 and generally had some of the highest overall summary scores (see Supplemental Digital Content 1 Appendix, Table 1 , available at: http://links.lww.com/JCRP/A82 ). Notably, question number 8, which assessed the ability of the PM to distinguish between a high-and low-quality program, consistently scored the lowest of all domains across all PMs and was therefore reported separately (see Supplemental Digital a Performance measures were ranked on a scale of 1 to 5 with 1 = strongly disagree, 5 = strongly agree, and then averaged.
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Content 1 Appendix, Tables 1 and 2 , available at: http:// links.lww.com/JCRP/A82 ). Quality of Care Committee scores generally agreed with the primary survey, differing in ranking appropriate utilization of CR as a top priority. After discussion and incorporation of survey comments, the QCC decided not to pursue diabetes self-management or appropriate utilization of CR because both were felt to be out of the locus of control of an individual CR program and would require signifi cant physician and hospital coordination. It was decided to make tobacco cessation a process measure rather than an outcome measure, because of the consistently reported feeling that tobacco cessation was diffi cult to accurately measure and modify in CR. Among the potential topics in the psychosocial risk category, the QCC decided to pursue depression as the fi rst PM, given that it is an important comorbidity, [16] [17] [18] is treatable in CR, [19] [20] [21] [22] and is strongly proven to be associated with mortality risks. [23] [24] [25] Of the 12 topics in the PR survey, improvement in sensation of dyspnea, improvement in functional capacity, improvement in health-related quality of life, and appropriate oxygen utilization had the highest mean scores and number of domains ranking in the top 5 (see Supplemental Digital Content 1 Appendix, Table 2 , available at: http://links. lww.com/JCRP/A82 ). These rankings validated the importance of the 2 previously developed PMs (improvement in health-related quality of life and improvement in functional capacity). After incorporation of comments, the QCC decided to further develop the improvement in sensation of dyspnea PM, because improvement in dyspnea is the primary patient symptom addressed by PR. Although appropriate oxygen utilization scored strongly as a topic for measure consideration, the QCC felt that there was not yet suffi cient peer-reviewed evidence to require uniform testing, prescription, and evaluation of oxygen adherence across all PR programs, so further development on this topic was suspended.
After drafting the initial PMs, we then sent the face validity survey to 144 CR and PR leadership individuals, with 82 (56.9%) completing the survey. Participants' characteristics were generally similar to the prioritization survey but this time represented a mixture of both CR and PR professionals ( Table 2 ) . Survey results are found in Table 3 and show that, nearly uniformly, the PMs scored between 4 and 5, indicating that participants agreed or strongly agreed on nearly all 8 domains as well as across PM language and defi nitions. Based upon comments submitted, additional minor modifi cations in language and defi nitions were made to each PM.
For feasibility and reliability testing, we recruited 16 sites (both CR and PR) across the United States to participate in abstracting up to 4 PMs at each site, with 12 sites completing at least 1 PM abstraction. The number of sites for each PM is shown in Table 4 , as well as the number of charts reviewed for each PM at each step of validation. The number of patients who met both the denominator and exclusion defi nitions for the tobacco cessation measure was small (52 patients) whereas 286 and 253 patients were evaluated for the blood pressure and functional capacity PMs numerator defi nitions, respectively. In general, both intrarater and interrater agreement was excellent ( κ ≥ 0.8) or good ( κ = 0.61-0.79) for most of the PMs. Abstractors struggled with operationalizing the exclusion defi nitions for both the depression and dyspnea PMs but otherwise had excellent intrarater and interrater reliability results. However, the tobacco cessation PM numerator showed low inter-and intrarater reliability and had the slowest abstractions times. After discussion with the QCC and chart abstractors, the QCC decided that the depression and dyspnea measure inconsistencies could be addressed with better PM defi nitions, but that the tobacco cessation PM should be simplifi ed and retested with a larger eligible population in the future. Current PMs (including the 2 previously validated pulmonary PMs), with their data defi nitions, algorithm, and frequently asked questions, can be found in the online Appendix (see Supplemental Digital Content 1, available at: http://links. lww.com/JCRP/A82 ) or on the AACVPR website.
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DISCUSSION
Using a methodical approach for identifi cation and validation of new PMs, we introduced 5 new PMs for use among both CR and PR programs across the United States. These were identifi ed through signifi cant engagement with Table 4 Validation Number of patients who met each criterion at each step of the analysis combined across all sites. For example, the blood pressure measure started with 350 charts at 10 sites. Of these, 295 met criteria for the denominator and 9 charts had exclusions. In total, 239 of the eligible 286 (83.6%) patients met criteria for the measure. There was some disagreement ( κ < 1.0) between raters at each step, so the data presented here are the average number at each validation step, recognizing that raters sometimes disagreed about which patients met the measure definitions.
c Calculated by dividing the numerator by the denominator after exclusions.
stakeholders including AACVPR membership, AACVPR national and regional leaders, and the QCC. Development was an iterative process with modifi cations made at each step to improve and clarify each PM on the basis of the feedback received. Overall, results suggest that these PMs should have strong AACVPR member buy-in, are feasible to implement, and, when applied to programs across the United States, should perform adequately to distinguish high-and low-quality programs. Such information will be valuable to payers, referring clinicians, and to the programs themselves as they will give them objective feedback on their performance and should stimulate changes in clinical practice and improvements in quality of care. The fi rst PM within cardiopulmonary rehabilitation was originally developed in 2007 and focused on CR referral. 27 This PM was validated and endorsed by the National Quality Forum, updated in 2010, and is currently undergoing an additional update. 14 , 28 Similarly, the 2 PR measures were initially endorsed by the National Quality Forum in January 2011.
9 , 10 Now, with the addition of the PM for dyspnea in PR as described in this article, PMs for the top 3 major outcomes of PR that have strong scientifi c evidence are developed and validated. In addition, although structure and process measures for CR programs were initially described in 2007, 27 this is the fi rst time any PM for CR programs has focused primarily on outcomes and been tested and validated. In the future, we anticipate that additional PMs will be developed and existing PMs will be updated and modifi ed as new information becomes available. We also anticipate assessing how effective these PMs are in improving the actual quality of CR and PR services.
One of the major impacts of these PMs will be their use in AACVPR program certifi cation and data registries 29 , 30 to assess CR and PR program quality. Beginning with the 2018 program certifi cation cycle, programs will be required to submit data on these new PMs as part of the application for AACVPR certifi cation. However, currently, no standards have been set at which a program would be certifi ed or otherwise denied certifi cation, although some data regarding expected mean exercise workloads in CR have recently been published. 31 Consequently, 2 of the major goals for this fi rst round of program certifi cation are to establish baseline PM data and to ensure that these PMs are incorporated into the individual treatment plans of programs across the United States. Then, when such data are created, collected, and submitted, clear standards for program quality can be set and justifi ed scientifi cally. To this end, both the cardiac and pulmonary registries are in the process of being modifi ed to capture all the necessary elements to evaluate program performance on these PMs.
Ultimately, the goal of these PMs is to ensure that all CR and PR programs in the United States are meeting or exceeding high-quality standards for patient care and that certifi cation through the AACVPR is a marker of true program quality. Over time, we anticipate that these PMs will be used in quality improvement projects and will help standardize and improve care.
These data should be viewed in light of several limitations. First, there was a low response rate to the fi rst prioritization survey, which suggests that these results may not be fully generalizable because they represent a select group of respondents. However, we still had 302 participants and survey responses were received from clinicians all over the United States. Second, during the validation, only a limited number of programs participated and chart abstractions varied substantially between PMs. This heterogeneity could mean that PMs might perform differently when used in settings other than the ones in which we tested them and have limited generalizability. This limitation may be overcome by future validation studies or as data about these PMs become available in AACVPR registries. Third, although the tobacco cessation PM had low reliability, this measure has now been simplifi ed and is currently undergoing additional testing. This initial low performance is not a critical problem because, just like every other PM introduced here, it will not be immediately used to guide certifi cation or reimbursement. This will allow the tobacco cessation measure to be retested before it is tied to any certifi cation or fi nancial outcomes.
CONCLUSIONS
We identifi ed, drafted, modifi ed, and validated 5 new PMs for use in cardiac and pulmonary rehabilitation programs across the United States. We anticipate that these PMs will be the beginning of a new focus on improving quality and consistency in cardiopulmonary rehabilitation care. Modifi cations will continue and new PMs will be validated. Ultimately, we believe that these PMs will help programs provide high-quality care and ultimately may be useful in future value-based purchasing agreements in the ever-changing landscape of US health care.
